5 unknown, 2 completed, 1 enrolling by invitation. 8 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 8 | Unknown 5, Completed 2, Enrolling by invitation 1 |
Follow NB-UVB: new trials by email Literature Review of NB-UVB trials Research Report on NB-UVB
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Apremilast in Combination with NBUVB and NBUVB Alone in Vitiligo Patients Apremilast with NB-UVB, NB-UVB - Vitiligo | Phase 4 | Enrolling by invitation | Dow University of Health Sciences | 30 | 2025-01-01 | 2025-03-11 |
| Evaluation of the Effect of Narrowband UVB Versus Methotrexate on Serum Chitotriosidase Level in Psoriasis Narrowband ultraviolet B, Methotrexate - Psoriasis | Phase 4 | Unknown | Aswan University Hospital | 30 | 2022-01-10 | 2022-06-22 |
| Topical Methotrexate Microemulsion in the Treatment of Plaque Psoriasis topical methotrexate micoemulsion, Excimer light, Narrow band ultraviolet B - Psoriasis, Methotrexate | Phase 4 | Unknown | Assiut University | 30 | 2021-10-01 | 2021-07-21 |
| Latanoprost Plus NB-UVB Versus Each Alone in Non-segmental Vitiligo: Clinical and Laboratory Evaluation NB-UVB, Latanoprost - Non-segmental Vitiligo | Phase 4 | Unknown | Shaimaa Fawzy Abdel-rady Abdel-latif | 150 | 2021-01-13 | 2023-08-09 |
| Evaluation of the Effect of Narrowband UVB Versus Methotrexate on Serum TWEAK Level in Psoriasis Narrowband ultraviolet B, Methotrexate - Psoriasis | Phase 4 | Unknown | Aswan University Hospital | 30 | 2020-12-13 | 2021-03-23 |
| Effectiveness of Narrow-band Ultraviolet B Combined With Topical Tacrolimus 0.03% in Treatment of Patients With Vitiligo NB-UVB, NB-UVB & Tacrolimus 0.03% - Vitiligo | Phase 4 | Unknown | South Valley University | 100 | 2017-09-01 | 2018-09-06 |
| Study of the Efficacy of Early Intervention With Secukinumab 300 mg s.c. Compared to Narrow-band UVB in Patients With New-onset Moderate to Severe Plaque Psoriasis Secukinumab, nb-UVB - Plaque Psoriasis | Phase 4 | Completed | Novartis Pharmaceuticals | 196 | 2017-03-27 | 2025-01-28 |
| Utilization of Narrow Band Ultraviolet B (UVB) Light Therapy and Etanercept for the Treatment of Psoriasis NB-UVB, Etanerept, Etanercept - Psoriasis | Phase 4 | Completed | Amgen | 86 | 2005-03-01 | 2013-05-24 |
Aswan University Hospital (2) · Amgen (1) · Assiut University (1) · Dow University of Health Sciences (1) · Novartis Pharmaceuticals (1) · Shaimaa Fawzy Abdel-rady Abdel-latif (1) · South Valley University (1)
Egypt (4) · Argentina (1) · Bulgaria (1) · Canada (1) · Denmark (1) · Estonia (1) · Finland (1) · Germany (1) · Hungary (1) · Pakistan (1) · Poland (1) · Spain (1) · Sweden (1) · Switzerland (1) · United Kingdom (1)
Moustafa A El Taieb (1) · Moustafa A El Taieb, Professor (1) · Moustafa A El Taieb, prof. (1) · Ramdan Saleh, MD (1)
PMID 15389191, PMID 15787822, PMID 18380206, PMID 19043379, PMID 20857129, PMID 20858386, PMID 25606333, PMID 25645671, PMID 27174314, PMID 28232140, PMID 28785349, PMID 29442137, PMID 29448838, PMID 31850114, PMID 41881197, PMID 42191094
2015 (1)